PCN120 - Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared With Cabacitaxel in Costa Rica, in Patients with Metastatic Castration-Resistant Prostate Cancer That Have Failed to Chemotherapy with Docetaxel

Autor: Obando, C.A., Desanvicente-Celis, Z., Gonzalez, L., Muschett, D., Gonzalez, F., Goldberg, P.
Zdroj: In Value in Health November 2014 17(7):A635-A635
Databáze: ScienceDirect